Phibro Animal Health Financial Statements
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Phibro Animal Health revenue and earnings
In fiscal 2026, Phibro Animal Health generated $1.52 billion in revenue, up 17.1% from fiscal 2025, its 6th consecutive year of revenue growth. Net income was $99.7 million (+106.6% year over year), for a net margin of 6.6% versus a median of 3.7% in the prior 5 years. Gross margin was 33.8% (up from 30.9%) and operating margin 12.8%.
Diluted earnings per share came in at $2.43, up from $1.19. Over the last 5 fiscal years, PAHC's revenue has grown at a 12.7% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Phibro Animal Health income statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 | FY 20182018-06-30 | FY 20172017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.52B | 1.30B | 1.02B | 977.89M | 942.26M | 833.35M | 800.35M | 828.00M | 819.98M | 764.28M |
| Revenue growth (YoY) | +17.12% | +27.37% | +4.07% | +3.78% | +13.07% | +4.12% | -3.34% | +0.98% | +7.29% | +1.70% |
| Cost of Revenue | 1.01B | 896.27M | 704.59M | 679.65M | 656.86M | 561.97M | 543.47M | 563.37M | 553.10M | 516.04M |
| Gross Profit | 512.51M | 399.94M | 313.09M | 298.24M | 285.40M | 271.38M | 256.88M | 264.62M | 266.88M | 248.24M |
| Operating Expenses | 318.12M | 289.48M | 259.78M | 226.39M | 206.41M | 196.51M | 187.69M | 181.40M | 167.95M | 150.31M |
| Research & Development | 24.55M | 23.73M | 29.19M | 24.39M | 20.83M | 17.76M | 13.74M | 12.09M | 10.00M | 9.44M |
| Selling, General & Admin | 318.12M | 289.48M | 259.78M | 226.39M | 206.41M | 196.51M | 187.69M | 181.40M | 167.95M | 150.31M |
| Operating Income | 194.40M | 110.47M | 53.31M | 71.85M | 78.99M | 74.87M | 69.19M | 83.23M | 98.93M | 97.93M |
| Interest Expense | 46.42M | 37.22M | 23.01M | 18.68M | 12.69M | 13.72M | 14.61M | 13.68M | 13.60M | 16.87M |
| Pretax Income | 137.35M | 67.99M | 10.92M | 54.07M | 72.33M | 66.47M | 55.51M | 71.50M | 88.07M | 80.54M |
| Income Tax | 37.63M | 19.73M | 8.50M | 21.46M | 23.15M | 12.08M | 21.96M | 16.79M | 23.19M | 15.93M |
| Net Income | 99.72M | 48.26M | 2.42M | 32.61M | 49.17M | 54.38M | 33.55M | 54.71M | 64.88M | 64.61M |
| Net Income growth (YoY) | +106.61% | +1897.68% | -92.59% | -33.69% | -9.58% | +62.09% | -38.68% | -15.67% | +0.41% | -21.89% |
| EPS (Basic) | 2.46 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.63 |
| EPS (Diluted) | 2.43 | 1.19 | 0.06 | 0.81 | 1.21 | 1.34 | 0.83 | 1.35 | 1.61 | 1.61 |
| Shares Outstanding (Basic) | 40.55M | 40.52M | 40.50M | 40.50M | 40.50M | 40.47M | 40.45M | 40.41K | 40.18K | 39.52K |
| Shares Outstanding (Diluted) | 40.96M | 40.68M | 40.52M | 40.50M | 40.50M | 40.50M | 40.50M | 40.52K | 40.38K | 40.04K |
| EBITDA | 245.91M | 156.07M | 89.49M | 105.86M | 111.69M | 106.75M | 101.53M | 110.79M | 125.87M | 123.94M |
| Gross Margin | 33.76% | 30.85% | 30.77% | 30.50% | 30.29% | 32.56% | 32.10% | 31.96% | 32.55% | 32.48% |
| Operating Margin | 12.81% | 8.52% | 5.24% | 7.35% | 8.38% | 8.98% | 8.65% | 10.05% | 12.06% | 12.81% |
| Net Margin | 6.57% | 3.72% | 24.00% | 3.33% | 5.22% | 6.53% | 4.19% | 6.61% | 7.91% | 8.45% |
This table shows 10 annual periods of Phibro Animal Health's income statement, from FY 2026 back to FY 2017, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow PAHC's reporting calendar. What is a income statement?